Article
The Synergistic Effect of Valsartan and LAF237…
Experimental Diabetes Research · 2011 · Min Shen, author Dongdong Sun, author Weijie Li, author Bing Liu, author Shenxu Wang, author Zheng Zhang, author Feng Cao, author Daisuke Koya, Academic Editor
Key facts
| Title | The Synergistic Effect of Valsartan and LAF237 [(S)-1-[(3-Hydroxy-1-Adamantyl)Ammo]acetyl-2-Cyanopyrrolidine] on Vascular Oxidative Stress and Inflammation in Type 2 Diabetic Mice |
|---|---|
| First author | Min Shen, author Dongdong Sun, author Weijie Li, author Bing Liu, author Shenxu Wang, author Zheng Zhang, author Feng Cao, author Daisuke Koya, Academic Editor |
| Journal | Experimental Diabetes Research |
| Published | Sep 20, 2011 |
| DOI | 10.1155/2012/146194 |
| Devices mentioned | K000364, K000365, K000568, K000973, K001064, K002080, K003846, K004010, K010362, K011738, K012324, K021513 and 36 more |
| Product codes mentioned | CEC, CFN, CFQ, CGA, DBM, FPA, JIT, JPA, JQB, LBR, LBS, LBT and 8 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1